期刊文献+

突变减毒志贺样毒素Ⅰ真核表达载体的构建及其抗卵巢癌的活性 被引量:3

Construction of recombinant eukaryotic expression vectors carrying genes encoding attenuated Shiga-like toxin Ⅰ mutant and their anti-oophoroma effect
下载PDF
导出
摘要 目的构建表达突变减毒的志贺样毒素Ⅰ(Shiga-liketoxin1,Stx1)的真核表达载体,并考察其抗人卵巢癌细胞SKOV3的活性。方法重叠PCR法构建毒性为原毒素毒性1/10和1/100的突变减毒Stx1编码序列,T-A克隆并测序后分别连入真核表达载体pcDNA3.1。转染SKOV3细胞,RT-PCR法检测Stx1mRNA在SKOV3细胞中的表达,观察突变减毒Stx1对SKOV3细胞周期的影响和致SKOV3细胞死亡的方式。使用SKOV3荷瘤裸鼠模型,不同毒性突变减毒Stx1真核表达载体经脂质体包裹后肿瘤局部注射给药,评价其体内抑瘤能力。结果突变减毒Stx1真核表达载体经酶切和测序鉴定与预期突变序列一致;RT-PCR证实转染后的SKOV3细胞中存在目的mRNA;体外实验观察到该载体转染可以使人卵巢癌SKOV3细胞的细胞周期阻滞于G2/M期,转染后SKOV3细胞死亡的主要途径是坏死;体内实验显示突变减毒Stx1真核表达载体可以抑制裸鼠体内SKOV3移植瘤的生长。结论通过重叠PCR方法获得2种突变减毒Stx1编码序列,成功构建了相应的真核表达载体,并证实该载体具有明显的抗卵巢癌活性。 Objective: To construct recombinant eukaryotic expression vectors carrying genes encoding attenuated Shiga-like toxin 1 mutant and to study their anti-oophoroma effect in vitro and in vivo. Methods: The genes encoding attenuated Shiga-like toxin 1 mutant were amplified by overlap PCR and then cloned into eukaryotic expression plasmid pcDNA3. 1. The recombinant plasmids were transfected into SKOV3 cells and RT-PCR was used determine the expression of Stx 1 mRNA in SKOV3 cells. The influence of attenuated Stx 1 on the cell cycle of SKOV3 cells and the mechanism by which Stx 1 induces apoptosis of SKOV3 cells were observed. Then Stx 1 with different cyotoxicites ( after packed by liposome) were intratumorally injected into immunodeficient mice harboring SKOV3 to assess their anti-oophoroma effect in vi- vo. Results: It was showed that the genes encoding attenuated Stx 1 mutant were successfully cloned into pcDNA3.1 and their mRNA expression in transfected SKOV3 cells was verified by RT-PCR. In vitro study showed that the constructed plasmid arrested SKOV3cells at G2/M stage. The post-transfection death of SKOV3 cells was mainly through necrosis as assessed by flow cytometry. In vivo study showed that the constructed plasmid had a significant anti-oophoroma effect on the growth of SKOV3 tumor in immunodefficient mice. Conclusion: Two sequences encoding attenuated Stx 1 mutant have been successfully constructed and expressed in eukaryotic expression system, which have been confirmed to have obvious anti-oophoroma effect in vitro and in vivo.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2006年第6期435-441,共7页 Chinese Journal of Cancer Biotherapy
基金 天津市卫生局科技基金(No.05KY32)
关键词 志贺样毒素Ⅰ 突变 减毒 真核表达 卵巢癌 Shiga-like toxin Ⅰ ( Stx1 ) mutation attenuation eukaryotic expression oophoroma
  • 相关文献

参考文献13

  • 1Sandvig K,van Deurs B.Entry of ricin and Shiga toxin into cells:Molecular mechanisms and medical perspectives[J].EMBO J,2000,19(22):5943-5950.
  • 2Nakajima H,Kiyokawa N,Katagiri YU,et al.Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance[J].J Biol Chem,2001,276(46):42915-42922.
  • 3O'Loughlin EV,Robins-Browne RM.Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells[J].Microbes Infect,2001,3(6):493-507.
  • 4Yamasaki S,Furutani M,Ito K,et al.Importance of arginine at position 170 of the a subunit of vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity[J].Microb Pathog,1991,11(1):1-9.
  • 5Tzipori S,Sheoran A,Akiyoshi D,et al.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome[J].Clin Microbiol Rev,2004,17(4):926-941.
  • 6Harrison LM,Cherla RP,van den Hoogen C,et al.Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells[J].Microb Pathog,2005,38(2-3):63-76.
  • 7Narayanan S,Surendranath K,Bora N,et al.Ribosome inactivating proteins and apoptosis[J].FEBS Lett,2005,579(6):1324-1331.
  • 8Cherla RP,Lee S-Y,Tesh VL.Shiga toxins and apoptosis[J].FEMS Microbiol Lett,2003,228(2):159-166.
  • 9Nakagawa I,Nakata M,Kawabata S,et al.Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells[J].Mol Microbiol,1999,33(6):1190-1199.
  • 10Kovbasnjuk O,Mourtazina R,Baibakov B,et al.The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer[J].Proc Natl Acad Sci,2005,102(52):19087-19092.

二级参考文献16

  • 1吴克复.两类白血病和两类白血病干细胞[J].白血病.淋巴瘤,2004,13(3):129-131. 被引量:6
  • 2Chandra J, Kaufmann SH. Apoptosis pathways in cancer progression and treatment. In: Finkel T & Gutkind JS. Signal transduction and human disease. New Jersey: Wiley-Interscience. 2003: 143-170
  • 3Chen GQ, Shi XG, Tang W, et al. Use of arsenic trioxide As2 O3 in the treatment of acute promyelocyte leukemia: I. As2 O3 exerts dosedependent dual effects on APL cells. Blood, 1997;89:3345-3353
  • 4Shen Y, Shen Z-X, Yan H, et al. Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage. Leukemia,2001; 15: 735-741
  • 5Porosnicu M, Nimmanapalli R, Nguyen D, et al. Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against BcrAbl-positive acute leukemia cells. Leukemia,2001; 15:772-778
  • 6Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As2 O3combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA,2004;101: 5328-5335
  • 7Fadeel B. Programmed cell clearance. Cell Mol Life Sci, 2003;60: 2575-2585
  • 8Bergsmedh A, Szeles A, Henriksson M, et al. Horizontal transfer of oncogenes by uptake of apoptoic bodies. Proc Natl Acad Sci USA,2001; 98: 6407-6411
  • 9Reiter I, Krammer B, Schwamberger G. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol, 1999; 163:1730-1732
  • 10Ronchetti A, Rovere P, Iezzi G, et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells and cytokines. J Immunol,1999; 163: 130-136

共引文献5

同被引文献37

  • 1Maurer C,Meunier D,Madec JY.Shiga toxin Stx2 production is promoted by enrofloxacin in experimental in vitro-selected mutants of Escherichia coli O157:H7 resistant to fluoroquinolones[J].Foodborne Pathog Dis,2009,6(2):257-259.
  • 2Matsumoto M,Suzuki M,Takahashi M,et al.Identification and epidemiological description of enterohemorrhagic Escherichia coli O157 strains producing low amounts of Shiga toxin 2 in Aichi Prefecture[J].Japan Jpn J Infect Dis,2008,61(6):442-445.
  • 3O'Loughlin EV,Robins-Browne RM.Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells[J].Microbes Infect,2001,3(6):493-507.
  • 4Whitworth JH,Fegan N,Keller J,et al.International comparison of clinical,bovine,and environmental Escherichia coli O157 isolates on the basis of Shiga toxin-encoding bacteriophage insertion site genotypes[J].Appl Environ Microbiol,2008,74(23):7447-7450.
  • 5Tzipori S,Sheoran A,Akiyoshi D,et al.Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome[J].Clin Microbiol Rev,2004,17(4):926-941.
  • 6Harrison LM,Cherla RP,van den Hoogen C,et al.Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells[J].Microb Pathog,2005,38(2-3):63-76.
  • 7Narayanan S,Surendranath K,Bora N,et al.Ribosome inactivating proteins and apoptosis[J].FEBS Lett,2005,579(6):1324-1331.
  • 8Cherla RP,Lee S-Y,Tesh VL.Shiga toxins and apoptosis[J].FEMS Microbiol Lett,2003,228(2):159-166.
  • 9Nakagawa I,Nakata M,Kawabata S,et al.Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells[J].Mol Microbiol,1999,33(6):1190-1199.
  • 10Kovbasnjuk O,Mourtazina R,Baibakov B,et al.The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer[J].Proc Natl Acad Sci U S A,2005,102(52):19087-19092.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部